Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad
- PMID: 35463902
- PMCID: PMC9019361
- DOI: 10.3389/fped.2022.834268
Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad
Abstract
Background: Dyskeratosis congenita (DC) is a rare inheritable disorder characterized by bone marrow failure and mucocutaneous triad (reticular skin pigmentation, nail dystrophy, and oral leukoplakia). Dyskeratosis congenita 1 (DKC1) is responsible for 4.6% of the DC with an X-linked inheritance pattern. Almost 70 DKC1 variations causing DC have been reported in the Human Gene Mutation Database.
Results: Here we described a 14-year-old boy in a Chinese family with a phenotype of abnormal skin pigmentation on the neck, oral leukoplakia, and nail dysplasia in his hands and feet. Genetic analysis and sequencing revealed hemizygosity for a recurrent missense mutation c.1156G > A (p.Ala386Thr) in DKC1 gene. The heterozygous mutation (c.1156G > A) from his mother and wild-type sequence from his father were obtained in the same site of DKC1. This mutation was determined as disease causing based on silico software, but the pathological phenotypes of the proband were milder than previously reported at this position (HGMDCM060959). Homology modeling revealed that the altered amino acid was located near the PUA domain, which might affect the affinity for RNA binding.
Conclusion: This DKC1 mutation (c.1156G > A, p.Ala386Thr) was first reported in a Chinese family with mucocutaneous triad phenotype. Our study reveals the pathogenesis of DKC1 c.1156G > A mutation to DC with a benign phenotype, which expands the disease variation database, the understanding of genotype-phenotype correlations, and facilitates the clinical diagnosis of DC in China.
Keywords: DKC1; c.1156G > A; dyskeratosis congenita syndrome; missense mutation; p.Ala386Thr.
Copyright © 2022 Wang, Li, Xiong, Zhou, Li and Wu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.BMC Med Genet. 2018 May 25;19(1):85. doi: 10.1186/s12881-018-0584-y. BMC Med Genet. 2018. PMID: 29801475 Free PMC article.
-
A Novel Variant and a Missense Variant Identified in the DKC1 Gene in Three Chinese Familieswith Dyskeratosis Congenita.Clin Cosmet Investig Dermatol. 2022 Sep 9;15:1837-1845. doi: 10.2147/CCID.S371794. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36111181 Free PMC article.
-
Identification of a novel mutation and a de novo mutation in DKC1 in two Chinese pedigrees with Dyskeratosis congenita.J Invest Dermatol. 2004 Sep;123(3):470-3. doi: 10.1111/j.0022-202X.2004.23228.x. J Invest Dermatol. 2004. PMID: 15304085
-
Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.Genes (Basel). 2022 Mar 11;13(3):496. doi: 10.3390/genes13030496. Genes (Basel). 2022. PMID: 35328050 Free PMC article. Review.
-
Dyskeratosis congenita.Oral Oncol. 2006 Apr;42(4):331-6. doi: 10.1016/j.oraloncology.2005.06.007. Epub 2005 Sep 2. Oral Oncol. 2006. PMID: 16140563 Review.
Cited by
-
Identification and Computational Analysis of a Novel Pathogenic DKC1 Variant Underlying X-Linked Dyskeratosis Congenita.Biochem Genet. 2025 Jul 9. doi: 10.1007/s10528-025-11187-z. Online ahead of print. Biochem Genet. 2025. PMID: 40634789
-
Case report: A novel mutation in RTEL1 gene in dyskeratosis congenita.Front Oncol. 2023 Mar 2;13:1098876. doi: 10.3389/fonc.2023.1098876. eCollection 2023. Front Oncol. 2023. PMID: 36937416 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources